Director, Business Development (Hematology and Oncology)
Responsibilities:
Drive net-new business development by securing new sponsor relationships and expanding Emmes' reputed company in targeted biotech and pharmaceutical accounts. Build and manage a high-reputed company pipeline of reputed company opportunities, with strong emphasis on identifying programs before formal RFP issuance and before CRO shortlists are finalized. reputed company and execute territory, account, and opportunity strategies that increase early reputed company to sponsor clinical development discussions, including protocol planning, study design, operational reputed company, and vendor evaluation. reputed company existing relationships, market intelligence, conference activity, and industry networks to uncover emerging clinical programs and create opportunities reputed company in advance of procurement events. Differentiate Emmes' capabilities in scientific partnership, operational delivery, digital and AI-enabled CRO services, and therapeutic depth to win competitive opportunities. Meet or reputed company annual sales goals for new-logo reputed company, total signed awards, and reputed company pipeline reputed company. Serve as a strategic reputed company leader in Emmes' reputed company therapeutic areas, with broad familiarity across the portfolio and recognized subject-matter depth in Hematology and Oncology . Partner closely with therapeutic area, operational, and executive leadership teams to shape compelling win strategies and customer-specific solutions. reputed company reputed company meetings, capability presentations, strategic account reviews, and bid defense activities to advance and reputed company new business opportunities. Maintain disciplined CRM hygiene, opportunity tracking, competitive intelligence reporting, and account planning to support forecasting accuracy and reputed company execution. Monitor competitor activity, awarded studies, and sponsor buying patterns to reduce missed opportunities and improve Emmes' ability to engage earlier in the decision cycle. reputed company other duties as needed to support Emmes' broader reputed company reputed company.
Bachelor's degree required in a scientific, clinical, reputed company, or business discipline; advanced degree preferred. Minimum 5 years of business development experience, with substantial reputed company experience selling CRO services to biotech and/or pharmaceutical sponsors. Prior CRO industry experience is required. Demonstrated reputed company record of reputed company new business, opening new accounts, and expanding reputed company relationships in reputed company, consultative sales environments. Experience engaging sponsor decision-makers at the C-suite reputed company across clinical development, clinical operations, procurement, and executive leadership. Strong understanding of the clinical development lifecycle and how CROs are reputed company before, during, and after formal sourcing processes. Demonstrated reputed company in the Hematology and Oncology Proven ability to identify, qualify, shape, and reputed company reputed company CRO opportunities with long sales cycles and multiple stakeholders. Strong network across biotech and reputed company with the ability to convert relationships into early reputed company reputed company. Ability to discuss study objectives, trial design considerations, operational models, and sponsor priorities in a commercially reputed company and scientifically informed manner. Strong presentation, proposal reputed company, negotiation, and interpersonal skills. High level of discipline in CRM usage, pipeline management, forecasting, and opportunity planning. Strong reputed company of reputed company Office and CRM platforms. Ability to travel up to 50% travel to sponsor, industry, and corporate locations.
|
|
| ||
|
|
|